Internet platform opens appointments for domestic live attenuated herpes zoster vaccination
Read Time:59 Second
Recently, Changchun BacTech Biotechnology Co., Ltd. announced that the company recently received the Drug Registration Certificate for the live attenuated herpes zoster vaccine from the State Drug Administration. This means that the world’s first marketing application for a live attenuated herpes zoster vaccine for adults aged 40 years and above has been approved in mainland China.
On the 2nd, Ali Health launched a domestic herpes zoster vaccination demand registration service, which allows users aged 40 and above with vaccination needs to fill in information online and subscribe to vaccination reminders.
According to several media reports, before the product was approved, there were not many options for shingles vaccine in the market. Only two herpes zoster vaccines were approved for the global market, and only one of them was available in China. The approval of the vaccine on the market not only enriches the choice of users, but also relaxes the age of vaccination for shingles vaccine to 40 years.
Herpes zoster is an acute infectious skin disease caused by the reactivation of the varicella-zoster virus that is latent in the body. The complication of shingles postherpetic neuralgia (PHN) is painful and unbearable for the patient.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating